Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the review of medical technologies guidance from the UK National Institute for Health and Care Excellence (NICE) ...

LONDON, Jan. 27, 2021 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, is pleased to announce a new publication showing that its PICO Single Use Negative ...

For years, orthopedic teams have increasingly used single-use, prophylactic negative pressure wound therapy (sNPWT) to reduce these complications. These dressings support healing by applying ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. –80 mm Hg single-use negative wound pressure therapy had ...

Smith & Nephew plc added new indications for use of its Pico 7 and Pico 14 single-use negative pressure wound therapy (sNPWT) systems. The FDA cleared the London-based device maker’s systems for ...

The committee noted considerable evidence to show the effectiveness of PICO in reducing rates of surgical site infections (18 studies) and seromas (7 studies). The company did meta-analyses using a ...

An estimated one in eight patients develops infections after surgery, which occur when bacteria enters the body through a surgical incision. And the rate is much higher – up to 40 per cent – among the ...